Targeting RNA G‐quadruplexes as new treatment strategy for C9orf72 ALS/FTD

Publisher： John Wiley & Sons Inc

E-ISSN： 1757-4684|10|1|4-6

ISSN： 1757-4676

Source： EMBO Molecular Medicine, Vol.10, Iss.1, 2018-01, pp. : 4-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

G‐quadruplex‐binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo

By  

EMBO Molecular Medicine, Vol. 10, Iss. 1, 2018-01 ,pp. : 22-31

John Wiley & Sons Inc

Access to resources Recommend Favorite

A proteomic network approach across the ALS‐FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain

By  

EMBO Molecular Medicine, Vol. 10, Iss. 1, 2018-01 ,pp. : 48-62

John Wiley & Sons Inc

Access to resources Recommend Favorite

CRISPR‐Cas9: how research on a bacterial RNA‐guided mechanism opened new perspectives in biotechnology and biomedicine

By  

EMBO Molecular Medicine, Vol. 7, Iss. 4, 2015-04 ,pp. : 363-365

John Wiley & Sons Inc

Access to resources Recommend Favorite

Europe's New Security Strategy: Challenges for Development Policy

By FAUST JÖRG   MESSNER DIRK  

The European Journal of Development Research, Vol. 17, Iss. 3, 2005-09 ,pp. : 423-436

Routledge Ltd

Access to resources Recommend Favorite

A Performance Measurement System for Planning and Controlling a BtoC E-Commerce Strategy

By Rangone Andrea   Balocco Raffaello  

Electronic Markets, Vol. 10, Iss. 2, 2000-04 ,pp. : 130-143

Routledge Ltd

Access to resources Recommend Favorite